An engineered 3D-printed realistic patient simulator: market assessment

工程 3D 打印的逼真患者模拟器：市场评估

• 批准号: 514324-2017
• 负责人: Kadem, Lyes
• 金额: $ 1.09万
• 依托单位: Concordia University
• 依托单位国家: 加拿大
• 项目类别: Idea to Innovation
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=618329
• 关键词: engineered; 3D; printed; realistic; patient

Cardiovascular disease is the first cause of death in Canada, in the United States and most occidental countries.Accurate diagnosis and treatment require high performance medical devices and continuous high-qualitymedical training. This is becoming hardly achievable using the "standard" medical education model.Significant changes have been recently affecting the world of medicine: 1) an important reduction in physicianteaching time; 2) a lower availability of patients as educational resources, 3) more strict medicolegal systems;4) accreditation and regulatory bodies putting more emphasis on continuous maintenance of competence. As aconsequence, relying on real patients is becoming a less desirable option for resident training and maintenanceof physician competence, leading to a significant increase in the demand for high-fidelity simulators. Fromanother side, newly developed implantable medical devices are required to undergo an extensive series ofbench testing. This includes not only performance testing of the device itself but also of its delivery system.Currently existing cardiac simulators are, however, not optimized for advanced medical training and forclose-to-real bench testing of medical devices. We have developed the first realistic complete heart simulatorcapable of reproducing normal and pathological conditions. The simulator is capable of reproducing normaland abnormal physiological pressure and flow conditions in anatomically correct heart cavities, providing amore realistic picture of the complex environment that will be experienced by the implantable medical deviceand by the medical trainee during the implantation procedure. The most important markets for our technologyare the growing markets for medical simulators and for implantable cardiovascular medical devices. Theobjective of this market assessment grant application is to define and size the most suitable market for ourtechnology before re-submitting our unsuccessful I2I phase I application

心血管疾病是加拿大、美国和大多数西方国家的头号死因。准确的诊断和治疗需要高性能的医疗设备和持续的高质量医学培训。这很难用“标准”医学教育模式来实现。最近，显著的变化正在影响医学界：1)物理和教学时间的显著减少；2)患者作为教育资源的可获得性降低；3)更严格的法医体系；4)认证和监管机构更加强调持续保持能力。作为一种反序列，依赖真实的患者正在成为住院医师培训和维护医生能力的不太可取的选择，导致对高保真模拟器的需求显著增加。另一方面，新开发的植入式医疗设备需要接受一系列广泛的台架测试。这不仅包括对设备本身的性能测试，也包括对其输送系统的性能测试。然而，目前现有的心脏模拟器并未针对高级医学培训和接近真实的医疗设备台式测试进行优化。我们开发了第一个逼真的完整心脏模拟器，能够再现正常和病理条件。该模拟器能够在解剖学上正确的心腔内再现正常和异常的生理压力和流动条件，为植入型医疗设备和医学实习生在植入过程中将经历的复杂环境提供更逼真的图像。对于我们的技术来说，最重要的市场是医疗模拟器和植入式心血管医疗设备不断增长的市场。此市场评估拨款申请的目标是在重新提交未成功的I2I第一阶段申请之前，为我们的技术定义和调整最合适的市场